Peter Svennilson is Director & 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM). They have made 50 open-market trades across 5 companies since 2014, most recently 2022-12-12.
CIK 0001606074
42 open-market purchases totalling $119.1M since 2014, against 8 sales. Across 42 scored buys the stock is up 12.8% at ninety days, and 6.9 points ahead of the S&P over the same stretch.
42 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 57% | 60% | 57% |
| Avg Move | -0.6% | +8.9% | +12.8% |
| Alpha | -0.3% | +7.9% | +6.9% |
| Scored | 42 | 42 | 42 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 20% | 60% |
| Avg Move | -0.1% | +8.6% | -15.7% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NGM | BUY | 2022-12-12 | 2022-12-14 | $4.98 | $1K | -16.1% | -0.6% | -26.5% |
| NGM | BUY | 2022-11-21 | 2022-11-23 | $5.00 | $202K | +1.5% | -11.7% | -18.3% |
| NGM | BUY | 2022-06-02 | 2022-06-06 | $13.03 | $877K | -7.5% | +2.2% | +6.1% |
| NGM | BUY | 2022-05-17 | 2022-05-19 | $13.33 | $4.0M | -5.6% | +0.1% | +20.8% |
| RAPT | SELL | 2021-08-20 | 2021-08-24 | $31.28 | $5.4M | +14.7% | +9.0% | +5.2% |
| RVMD | SELL | 2021-04-26 | 2021-04-28 | $42.79 | $6.5M | -12.9% | -12.5% | -18.1% |
| RVMD | SELL | 2021-04-08 | 2021-04-12 | $44.52 | $5.8M | +3.0% | -19.4% | -17.5% |
| RVMD | SELL | 2021-04-05 | 2021-04-07 | $47.09 | $7.4M | -13.8% | -35.2% | -31.1% |
| CNST | SELL | 2021-02-17 | 2021-02-19 | $36.95 | $370K | -30.7% | -24.1% | -43.4% |
| RVMD | SELL | 2020-11-16 | 2020-11-18 | $36.40 | $147.6M | +15.6% | +8.3% | +27.2% |
| RAPT | SELL | 2020-09-22 | 2020-09-22 | $30.85 | $18.8M | -4.6% | +2.9% | -32.0% |
| RAPT | SELL | 2020-08-17 | 2020-08-19 | $22.75 | $24.5M | +4.4% | +47.0% | -35.5% |
| NGM | BUY | 2020-08-13 | 2020-08-17 | $17.65 | $2.3M | -8.2% | -1.1% | +6.1% |
| NGM | BUY | 2020-07-28 | 2020-07-30 | $17.99 | $148K | +0.1% | -0.8% | -7.8% |
| NGM | BUY | 2020-07-22 | 2020-07-23 | $18.00 | $3K | +9.5% | +3.6% | -5.6% |
| NGM | BUY | 2020-04-08 | 2020-04-09 | $14.95 | $3.4M | +5.0% | +45.4% | +29.9% |
| NGM | BUY | 2020-04-03 | 2020-04-07 | $14.17 | $3.9M | +1.4% | +33.5% | +24.3% |
| NGM | BUY | 2020-03-31 | 2020-04-02 | $12.40 | $6.0M | +19.4% | +34.0% | +51.6% |
| NGM | BUY | 2020-03-23 | 2020-03-25 | $11.89 | $7.1M | -1.8% | +28.6% | +64.0% |
| NGM | BUY | 2020-03-19 | 2020-03-23 | $11.68 | $6.8M | +2.9% | +29.2% | +84.0% |
| NGM | BUY | 2020-03-05 | 2020-03-06 | $18.00 | $150K | -44.1% | -25.1% | +8.7% |
| NGM | BUY | 2020-03-02 | 2020-03-04 | $17.97 | $2.3M | -34.7% | -31.6% | +11.9% |
| NGM | BUY | 2020-02-26 | 2020-02-28 | $17.91 | $2.0M | -17.5% | -29.0% | +9.7% |
| NGM | BUY | 2020-02-06 | 2020-02-10 | $15.96 | $717K | -1.0% | -6.1% | +35.8% |
| NGM | BUY | 2019-11-11 | 2019-11-13 | $12.00 | $180 | +21.5% | +45.0% | +26.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| NRIX |
| 10,307 |
| $251K |
| GRTS | 3,102,934 | $100K |
| Total | $406.2M |
Shares reported on the most recent Form 4, priced at the 2022-12-14 close.
| Scored | 5 | 5 | 5 |